Cyclacel Pharmaceuticals Inc. conducted a special meeting of shareholders on September 4, 2025. During this virtual meeting, several proposals were put forward and approved. One proposal involved the issuance of Cyclacel common stock to Fitters Parent, which received approval. Another approved proposal pertained to the potential issuance of more than 20% of the issued and outstanding shares of Cyclacel common stock. Additionally, a proposal to amend the company's certificate of incorporation to change its corporate name to Bio Green Med Solution, Inc. was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-026676), on September 05, 2025, and is solely responsible for the information contained therein.